Meiogenix
Edit

Meiogenix

http://www.meiogenix.com/
Last activity: 14.09.2026
Active
Categories: AgriTechBioTechCommerceProductTechnology
Meiogenix is a French biotech company that holds an exclusive and worldwide license for a technology that modulates the frequency of homologous recombination in eukaryotic cells. This technology facilitates the natural process that introduces genetic diversity in organisms allowing the generation of novel natural varieties with commercial potential.
Mentions
5
Total raised: $13M
Founded date: 2010

Investors 4

Funding Rounds 1

DateSeriesAmountInvestors
14.12.2021Series A$13M-

Mentions in press and media 5

DateTitleDescription
19.03.2026🎥 Ag’s new toolkit: AI, genomics, and robotics converge at World Agri-TechFrom new modes of action in crop protection to fleets of physical AI agents, founders at World Agri-Tech in San Francisco shared how converging technologies from AI and genomics to robotics are reshaping agriculture. We’ll share the full in...
19.08.2022Meet Jenny Rooke, founder and Managing Partner at Genoa VenturesGenoa Ventures invests at the intersection of biology and technology Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are more startups than ...
16.12.2021Reddit is—finally—going publicThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. It’s official. Reddit announced yesterday that it had confidentially filed for an IPO with the SE...
14.12.2021Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova PartnersParis, France, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced today the closing of a $13 million (€11 millio...
14.12.2021Meiogenix Announces $13 Million Series A Financing Round Led by Sofinnova PartnersParis, France, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Meiogenix, an agriculture biotech company using the process of Chromosome Editing to expand genetic diversity in food and agriculture, announced today the closing of a $13 million (€11 millio...

Reviews 0

Sign up to leave a review

Sign up Log In